Earnings Preview: Corcept Therapeutics
Portfolio Pulse from Benzinga Insights
Corcept Therapeutics (NASDAQ:CORT) is scheduled to release its quarterly earnings report on February 15, 2024, with an estimated EPS of $0.26. Analysts and investors are keen on whether the company will surpass this estimate and provide positive guidance for the next quarter. Historical data shows mixed reactions in stock price to past earnings performances, with the last quarter's beat followed by a 9.97% drop. Shares are currently trading at $23.05, up 4.48% over the last year.
February 14, 2024 | 4:01 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Corcept Therapeutics is expected to report an EPS of $0.26 for the upcoming quarter. Historical performance shows varied stock price reactions to earnings announcements.
Given the historical volatility in Corcept Therapeutics' stock price post-earnings, the upcoming report could lead to neutral short-term price movement. The company's past performance indicates that while it has the potential to beat estimates, the market's reaction, especially concerning guidance for future quarters, is unpredictable. The recent 9.97% drop after a beat suggests investor sentiment may not solely hinge on surpassing EPS estimates.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100